文献速递甲状腺疾病

新生儿先天性甲状腺功能减退症筛查:不同TSH阈值的检测性能评估

Newborn Screening for Primary Congenital Hypothyroidism: Estimating Test Performance at Different TSH Thresholds.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该研究在英国多族裔人群中开展前瞻性主动监测,随访3年,评估新生儿血斑TSH筛查在6、8、10 mU/L阈值下的检测性能。永久性原发性CH发生率为每万活产5.3例(95%CI 4.8–5.8)。与10 mU/L相比,8 mU/L的阳性相对似然比为1.20(95%CI 0.82–1.75),提示8 mU/L可能优于现行国家标准,需进一步评估。

要点

  • 永久性原发性CH发生率为5.3/10000(95%CI 4.8–5.8)。
  • 本地阈值下筛查灵敏度96.76%、特异度99.97%、阳性预测值66.88%。
  • 8 mU/L的阳性rLR为1.20(95%CI 0.82–1.75),优于10 mU/L但需进一步验证。

核心结论

  • 筛查项目整体性能良好。
  • TSH阈值8 mU/L(相对10 mU/L)的阳性相对似然比为1.20(95%CI 0.82–1.75),可能优于现行国家标准,需进一步评估。
  • 应进一步研究暂时性CH对筛查政策的影响。

研究设计与样本

  • 前瞻性主动监测,2011年6月至2012年6月,随访结局3年。
  • 多族裔人群中已建立新生儿血斑筛查,由临床医生上报<5岁因临床表现或筛查假阳性而接受检查的儿童。
  • 计算相对似然比(rLR),比较血斑TSH阈值6 mU/L、8 mU/L与全国推荐10 mU/L(假定阳性标准)。
  • 永久性原发性CH由3年随访时临床医生报告仍需T4治疗确定。

主要发现

  • 共629名新生儿(58.3%为女孩,58.7%为白人)因筛查假定阳性接受检查。
  • 共21名儿童(52.4%为女孩,52.4%为白人)因临床表现接受检查。
  • 432名儿童在3年随访时仍在治疗。
  • 永久性CH发生率为每10000名婴儿5.3例(95%CI 4.8–5.8)。
  • 使用本地应用阈值时,灵敏度、特异度、阳性预测值分别为96.76%、99.97%、66.88%。

关键数值与推荐

  • 比较的血斑TSH阈值:6 mU/L、8 mU/L,参照全国推荐标准10 mU/L(用于假定阳性结果)。
  • 永久性原发性CH定义:3年随访时临床医生报告仍需继续T4治疗。
  • 筛查性能(本地应用阈值):灵敏度96.76%、特异度99.97%、阳性预测值66.88%。
  • 阳性rLR:8 mU/L为1.20(95%CI 0.82–1.75),6 mU/L为0.52(95%CI 0.38–0.72)。
  • 阴性rLR:8 mU/L为0.11(95%CI 0.03–0.36),6 mU/L为0.11(95%CI 0.06–0.20)。

临床怎么用

  • 现行新生儿血斑TSH筛查项目整体表现良好,可继续作为原发性CH的筛查手段。
  • 8 mU/L阈值相对10 mU/L的阳性rLR为1.20,提示可能提高检出,但证据尚不足以直接改变国家筛查标准,需进一步评估。
  • 临床医生应按现行国家推荐标准判读筛查假定阳性结果,并关注随访中T4需求变化以区分永久性与暂时性CH。

局限性

  • 原文摘要未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Active surveillance of primary congenital hypothyroidism (CH) in a multiethnic population with established newborn bloodspot screening. OBJECTIVE: To estimate performance of newborn screening for CH at different test thresholds and calculate incidence of primary CH. DESIGN: Prospective surveillance from June 2011 to June 2012 with 3-year follow-up of outcomes. Relative likelihood ratios (rLRs) estimated to compare bloodspot TSH test thresholds of 6 mU/L and 8 mU/L, with the nationally recommended standard of 10 mU/L for a presumptive positive result. SETTING: UK National Health Service. PATIENTS: Clinician notification of children aged <5 years investigated following clinical presentation or presumptive positive screening result. MAIN OUTCOME MEASURE(S): Permanent primary CH status determined by clinician report of continuing T4 requirement at 3-year follow-up. RESULTS: A total of 629 newborns (58.3% girls; 58.7% white ethnicity) were investigated following presumptive positive screening result and 21 children (52.4% girls; 52.4% white) after clinical presentation; 432 remained on treatment at 3-year follow-up. Permanent CH incidence was 5.3 (95% CI, 4.8 to 5.8) per 10,000 infants. With use of locally applied thresholds, sensitivity, specificity, and positive predictive value were 96.76%, 99.97%, and 66.88%, respectively. Compared with a TSH threshold of 10 mU/L, positive rLRs for 8 mU/L and 6 mU/L were 1.20 (95% CI, 0.82 to 1.75) and 0.52 (95% CI, 0.38 to 0.72), and negative rLRs were 0.11 (95% CI, 0.03 to 0.36) and 0.11 (95% CI, 0.06 to 0.20), respectively. CONCLUSIONS: Screening program performance is good, but a TSH threshold of 8 mU/L appears superior to the current national standard (10 mU/L) and requires further evaluation. Further research should explore the implications of transient CH for screening policy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Knowles RL, Oerton J, Cheetham T, et al. Newborn Screening for Primary Congenital Hypothyroidism: Estimating Test Performance at Different TSH Thresholds. J Clin Endocrinol Metab. 2018. PMID: 30113641. doi:10.1210/jc.2018-00658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。